SMi's Pre-Filled Syringes and Injectable Drug Devices 12th January to 13th January 2022, Virtual Conference: Online Access Only Conference: 12 - 13 January 2022 Focus Day: 11 January 2022 Location: Virtual Conference: Online Access Only Website: http://pre-filled-syringes.com/pharmajournalist/WL Sponsored by: BD Medical - Pharmaceutical Systems, Crux, Nemera, Zeon Europe GmbH Chaired by: Bjørg Kaae Hunter, Department Manager, […]

SMi’s 10th Annual Pharmaceutical Microbiology UK Conference  Conference: 17 - 18 January 2022 Workshops: 19 January 2022 Location: Virtual Conference: Online Access Only   Website: http://www.pharma-microbiology.com/PJwl Sponsored by: CTL-MAT, Ecolab and Microgenetics Chaired by: Di Morris, Clinical Auditor, AstraZeneca Exploring Robust Risk-Based Microbiological Control Strategy SMi’s flagship microbiology conference is celebrating its 10 year anniversary. The conference taking […]

The 3rd Glioblastoma Drug Development Summit is the only industry led forum for large pharma, biotech and academic KOLs to unite under the common goal of accelerating the practical translation and clinical development of meaningful therapies for the treatment of glioblastoma. Through investigating the clinical implementation of diverse mechanisms of action, including, DNA damage repair, immunotherapy, oncolytic viruses, cholesterol […]

SMi’sTransdermal and Microneedle Delivery 24-25 January 2022 Workshop: 26th January 2022 Virtual Conference: Online Access Only www.transdermal-microneedle-delivery.co.uk/PharmajournalistWL #SMiTransdermal Sponsored by: LTS Lohmann Therapie-Systeme AG and QuadMedicine Co-Chaired by: Sanjiv Sharma, Senior Lecturer in Medical Engineering, Swansea University Tycho Speaker, Director, Drug Delivery and Biomaterials, AbbVie Ltd SMi's inaugural conference: Transdermal and Microneedle delivery will take place on 24th - 25th January […]

It is clear the world of TGF-β contains vast potential and excitement, in the past year alone we have seen great advances, clinical setbacks, and novel insights into the role of TGF-β. Over the last 12 months, we have seen so many highs and lows, including clinical updates from large pharma such as Novartis, Oncotelic […]

The 5th Annual PARP, ATR & DDR Inhibitors Summit is the one-of-a-kind industry-focused summit dedicated to bringing new and novel next-generation DDR therapeutics to the clinic and finding optimal treatment combinations to expand application in multiple cancer indications. This is the key in-person biopharma conference for any research team developing inhibitors of specific DDR targets, […]

Built with biopharmaceutical industry insights, this conference will bring together key opinion leaders from Europe and the rest of the world to delve deep into the challenges associated with successfully designing and developing the next-generation of mRNA-based vaccines & therapeutics with improved specificity, delivery & efficacy for immuno-oncology, infectious diseases and beyond. With 20+ pioneering […]

Decipher Mechanisms of Action, Understand Clinical Data & Ignite Partnership Opportunities to Accelerate Your Microbiome Research Whilst emerging phase 3 data is set to ignite investment and uncover the reality of microbiome-based therapeutics, there remain analytical challenges and translational bottlenecks that the community must come together to overcome, to redefine biopharmaceutical treatment and diagnostic options. […]

Heart failure affects about 6.2 million people in the United States, with half of the patients having heart failure with preserved ejection fraction (HFpEF) and counting. Yet, there is no treatment for this form of the disease as HFpEF is a heterogeneous syndrome and, like other disease areas, this makes it difficult to develop effective […]

Returning for its fifth year, the Antigen-Specific Immune Tolerance Summit will lean into the industry’s key challenges of understanding the mechanisms inducing tolerance, characterizing driver antigens of disease, monitoring immune response, and accelerating durable therapies into the clinic. This is your comprehensive guide to define your drug development strategy for 2022 and delve into the therapeutic opportunity […]